Showing results 1 to 3 of 3
Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors Kang, Da Hyun; Park, Cheol-Kyu; Chung, Chaeuk; Oh, In-Jae; Kim, Young-Chul; Park, Dongil; Kim, Jinhyun; et al, IMMUNE NETWORK, v.20, no.3, 2020-06 |
Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer Kim, C. G.; Kim, K. H.; Pyo, K-H; Xin, C-F; Hong, M. H.; Ahn, B-C; Kim, Y.; et al, ANNALS OF ONCOLOGY, v.30, no.7, pp.1104 - 1113, 2019-07 |
Tumour-infiltrating bystander CD8(+) T cells activated by IL-15 contribute to tumour control in non-small cell lung cancer Leem, Galam; Jeon, Minwoo; Kim, Kun Woo; Jeong, Seongju; Choi, Seong Jin; Lee, Yong Joon; Kim, Eui-Soon; et al, THORAX, v.77, no.8, pp.769 - 780, 2022-08 |
Discover